Adverse events (AEs)
| CS1002 N=83 | Simple linctus N=79 | |
|---|---|---|
| AEs, n (%) | Total N (%) | Total N (%) |
| Number of participants with an AE | 17 (20.5) | 21 (27.6) |
| Nervous system disorders | 7 (8.4) | 10 (13.2) |
| Headache | 5 (6.0) | 9 (11.8) |
| Dizziness | 1 (1.2) | 2 (2.6) |
| Respiratory, thoracic and mediastinal disorders | 8 (9.6) | 9 (11.8) |
| Oropharyngeal pain | 2 (2.4) | 4 (5.3) |
| Cough | 2 (2.4) | 3 (3.9) |
| Productive cough | 3 (3.6) | 1 (1.3) |
| Dyspnoea | 0 (0.0) | 2 (2.6) |
| Gastrointestinal disorders | 5 (6.0) | 2 (2.6) |
| Diarrhoea | 3 (3.6) | 0 (0.0) |
| Abdominal pain upper | 2 (2.4) | 0 (0.0) |
| General disorders and administration site conditions | 0 (0.0) | 5 (6.6) |
| Pain | 0 (0.0) | 3 (3.9) |
| Fever | 0 (0.0) | 2 (2.6) |
| Infections and infestations | 1 (1.2) | 2 (2.6) |
| Lower respiratory tract infection | 0 (0.0) | 2 (2.6) |
Treated set population. AEs reported for >1 participant.